When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. A week ago, UAE Team Emirates revealed that Aru would have to miss the Giro d'Italia in May after ...
DUBLIN -- Medtronic plc today announced that its Protégé(TM) GPS(TM) self-expanding peripheral stent system has received approval from the U.S. Food and Drug Administration (FDA) for the treatment of ...
Zacks Investment Research on MSN
BDX secures CE mark for Revello stent to treat iliac artery disease
Becton, Dickinson and Company BDX, popularly known as BD, recently announced that it has received CE Mark approval in the European Union for its Revello Vascular Covered Stent. With this approval, BD ...
The FDA approved W.L. Gore’s balloon expandable stent graft for use in the iliac artery, making it the first and only device of its kind approved to treat peripheral artery disease in this part of the ...
Twelve-Month Data Presented at TCT 2012 Support Safety and Efficacy of Epic Stent in Iliac Stenting NATICK, Mass. -- Boston Scientific Corporation reports twelve-month clinical endpoint data from the ...
VISIBILITY Iliac and DURABILITY Iliac Studies Evaluate the Safety and Effectiveness of Balloon Expandable and Self-Expanding Stents in Treating Iliac Artery Disease Each study is designed to evaluate ...
BD’s Revello Vascular Covered Stent receives CE marking to treat atherosclerotic lesions in common and external iliac arteries: Franklin Lakes, New Jersey Monday, March 9, 2026, ...
Gore has announced that the Gore Viabahn VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) has received approval from the Food and Drug Administration (FDA). Gore has announced that the Gore ...
Self-expanding polyethylene terephthalate and polytetrafluoroethylene (PTFE)-covered stents have been shown to decrease the need for repeat procedures in the iliac artery. [33] Similar to surgical ...
EL PASO, Texas -- William Beaumont Army Medical Center became the first military treatment facility in the Department of Defense to use the first "off-the-shelf" aortic branch device (stent graft) ...
NATICK, Mass., Oct. 23, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) reports twelve-month clinical endpoint data from the ORION trial, which demonstrated robust safety and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results